NHC Relative Valuation
NHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NHC is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.67
P/B
Median3y
1.42
Median5y
1.36
6.50
FCF Yield
Median3y
3.19
Median5y
5.92
Competitors Valuation Multiple
The average P/S ratio for NHC's competitors is 0.58, providing a benchmark for relative valuation. National Healthcare Corp Corp (NHC) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 25.75%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is National Healthcare Corp (NHC) currently overvalued or undervalued?
What is National Healthcare Corp (NHC) fair value?
How does NHC's valuation metrics compare to the industry average?
What is the current P/B ratio for National Healthcare Corp (NHC) as of Jul 08 2025?
What is the current FCF Yield for National Healthcare Corp (NHC) as of Jul 08 2025?
What is the current Forward P/E ratio for National Healthcare Corp (NHC) as of Jul 08 2025?